Chlamydia trachomatis infections are a common sexually transmitted infection in the United States in which the majority of cases are asymptomatic. Due to this asymptomatic nature, as well as the serious health issues that arise from untreated infections in women, the Centers for Disease Control and Prevention (CDC) recommends a screening policy that annually targets women between the ages of 15 and 25 or older women with risk factors. There is little evidence supporting the efficacy of only screening women and doing so once per year. Through a stochastic epidemiological model, we investigate a variety of screening policies within a college setting and evaluate their impact on infection prevalence. We have developed a MATLAB program using an...
Objectives: To evaluate the cost effectiveness of a systematic screening programme for asymptomatic ...
AbstractObjectiveTo estimate the cost-effectiveness of a systematic one-off Chlamydia trachomatis (C...
Objective. To estimate cost effectiveness of opportunistic screening for Chlamydia trachomatis (CT) ...
The design of a screening program for asymptomatic genital infections with Chlamydia trachomatis, re...
The design of a screening program for asymptomatic genital infections with Chlamydia trachomatis, re...
Chlamydia infection (CT) is caused by the bacterium, Chlamydia trachomatis, and is one of the most c...
Chlamydia trachomatis (CT) is the most commonly reported notifiable sexually transmitted disease (ST...
On the basis of a review of the current literatureand recommendations, the American Collegeof Preven...
To estimate the cost-effectiveness of a systematic one-off Chlamydia trachomatis (CT) screening prog...
Chlamydia trachomatis is the most prevalent sexually transmitted bacteria in the US and results in r...
BACKGROUND: Several developed countries have initiated chlamydia screening programmes. Screening for...
Background: Models commonly used for the economic assessment of chamydial screening programs do not ...
BACKGROUND: Published individual-based, dynamic sexual network modelling studies reach different con...
Although routine screening of all sexually active adolescent females for Chlamydia trachomatis infec...
OBJECTIVE: To review systematically and critically, evidence used to derive estimates of costs and c...
Objectives: To evaluate the cost effectiveness of a systematic screening programme for asymptomatic ...
AbstractObjectiveTo estimate the cost-effectiveness of a systematic one-off Chlamydia trachomatis (C...
Objective. To estimate cost effectiveness of opportunistic screening for Chlamydia trachomatis (CT) ...
The design of a screening program for asymptomatic genital infections with Chlamydia trachomatis, re...
The design of a screening program for asymptomatic genital infections with Chlamydia trachomatis, re...
Chlamydia infection (CT) is caused by the bacterium, Chlamydia trachomatis, and is one of the most c...
Chlamydia trachomatis (CT) is the most commonly reported notifiable sexually transmitted disease (ST...
On the basis of a review of the current literatureand recommendations, the American Collegeof Preven...
To estimate the cost-effectiveness of a systematic one-off Chlamydia trachomatis (CT) screening prog...
Chlamydia trachomatis is the most prevalent sexually transmitted bacteria in the US and results in r...
BACKGROUND: Several developed countries have initiated chlamydia screening programmes. Screening for...
Background: Models commonly used for the economic assessment of chamydial screening programs do not ...
BACKGROUND: Published individual-based, dynamic sexual network modelling studies reach different con...
Although routine screening of all sexually active adolescent females for Chlamydia trachomatis infec...
OBJECTIVE: To review systematically and critically, evidence used to derive estimates of costs and c...
Objectives: To evaluate the cost effectiveness of a systematic screening programme for asymptomatic ...
AbstractObjectiveTo estimate the cost-effectiveness of a systematic one-off Chlamydia trachomatis (C...
Objective. To estimate cost effectiveness of opportunistic screening for Chlamydia trachomatis (CT) ...